Weidong Han - Concepedia

Author

Weidong Han

Chinese PLA General Hospital ORCID

Also Known As

Han, W., Han, Weidong, Hu, Ming Chang, Mac Namee, Brian, W Han, W-D Han, W. Han, WEIDONG HAN, Wanrong Han, Wei Dong Han

608

Publications

23.3K

Citations

H-Index

148

Concepts

All Affiliations

Chinese PLA General Hospital Chinese People's Liberation Army Chinese Academy of Sciences Peking University Nankai University

About

Weidong Han is an author at Chinese PLA General Hospital specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	50	3.1K
2	Health Sciences	11	11	952
3	Engineering	5	5	187
4	Natural Sciences	2	2	97
5	Public Health	2	2	50

Weidong Han

152

Publications

14.4K

Citations

H-Index

Page 1

	Year	Citations
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells Zhiwei Zhou, Huabin He, Kun Wang, Science	2020	1.3K
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy Mengze Lv, Meixia Chen, Rui Zhang, Cell Research	2020	927
LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b Dongdong Ti, Haojie Hao, Chuan Tong, Journal of Translational Medicine	2015	646
Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer Baolin Liu, Xueda Hu, Kaichao Feng, Nature Cancer	2021	444
Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia Quanshun Wang, Yao Wang, Haiyan Lv, Molecular Therapy	2014	403
TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors Na Tang, Chen Cheng, Xingying Zhang, JCI Insight	2020	362
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial Chunmeng Wang, Zhiqiang Wu, Yao Wang, Clinical Cancer Research	2016	323
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial Yao Wang, Meixia Chen, Zhiqiang Wu, OncoImmunology	2018	319
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia Hanren Dai, Zhiqiang Wu, Hejin Jia, Journal of Hematology & Oncology	2020	312
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers Kaichao Feng, Yang Liu, Yelei Guo, Protein & Cell	2017	304

Page 1